Analysts expect Albemarle Corporation (NYSE:ALB) to post sales of $733.32 million for the current fiscal quarter, Zacks Investment Research reports. Six analysts have made estimates for Albemarle Corporation’s earnings, with estimates ranging from $715.14 million to $745.10 million. Albemarle Corporation reported sales of $654.01 million in the same quarter last year, which would suggest a positive year over year growth rate of 12.1%. The firm is expected to issue its next quarterly earnings results on Monday, November 6th.

According to Zacks, analysts expect that Albemarle Corporation will report full-year sales of $733.32 million for the current financial year, with estimates ranging from $2.92 billion to $3.00 billion. For the next financial year, analysts forecast that the firm will report sales of $3.20 billion per share, with estimates ranging from $3.09 billion to $3.42 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research analysts that cover Albemarle Corporation.

Albemarle Corporation (NYSE:ALB) last released its earnings results on Monday, August 7th. The specialty chemicals company reported $1.13 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.11 by $0.02. The firm had revenue of $737.25 million during the quarter, compared to analyst estimates of $735.50 million. Albemarle Corporation had a net margin of 31.49% and a return on equity of 11.59%. The business’s revenue was up 10.1% on a year-over-year basis. During the same quarter last year, the business earned $0.93 EPS.

Several research analysts have recently weighed in on the stock. Goldman Sachs Group, Inc. (The) cut shares of Albemarle Corporation from a “buy” rating to a “neutral” rating and boosted their price target for the company from $139.66 to $142.00 in a research report on Friday. CIBC assumed coverage on shares of Albemarle Corporation in a research report on Thursday, August 17th. They set an “outperform” rating and a $133.00 price target on the stock. Piper Jaffray Companies reissued an “overweight” rating and set a $47.00 price target on shares of Albemarle Corporation in a research report on Thursday, June 29th. SunTrust Banks, Inc. cut shares of Albemarle Corporation from a “buy” rating to a “hold” rating and set a $121.00 price target on the stock. in a research report on Wednesday, August 9th. Finally, KeyCorp upped their target price on shares of Albemarle Corporation from $120.00 to $125.00 and gave the company an “overweight” rating in a research report on Monday, June 12th. Nine equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Albemarle Corporation presently has an average rating of “Buy” and an average price target of $116.47.

WARNING: “$733.32 Million in Sales Expected for Albemarle Corporation (ALB) This Quarter” was published by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another website, it was illegally stolen and reposted in violation of US & international copyright law. The legal version of this article can be viewed at https://www.americanbankingnews.com/2017/10/06/733-32-million-in-sales-expected-for-albemarle-corporation-alb-this-quarter-2.html.

Albemarle Corporation (NYSE ALB) traded down 2.69% during midday trading on Friday, hitting $135.91. 926,090 shares of the stock traded hands. The firm has a market cap of $15.01 billion, a PE ratio of 17.38 and a beta of 1.67. The stock has a 50-day moving average of $124.49 and a 200 day moving average of $113.88. Albemarle Corporation has a 52-week low of $76.32 and a 52-week high of $140.10.

The company also recently announced a quarterly dividend, which was paid on Monday, October 2nd. Investors of record on Friday, September 15th were paid a dividend of $0.32 per share. The ex-dividend date of this dividend was Thursday, September 14th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.92%. Albemarle Corporation’s payout ratio is 16.41%.

In related news, EVP Karen G. Narwold sold 11,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $115.95, for a total transaction of $1,333,425.00. Following the sale, the executive vice president now directly owns 36,620 shares in the company, valued at $4,246,089. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Matthew Juneau sold 5,397 shares of the company’s stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $115.77, for a total transaction of $624,810.69. Following the sale, the executive vice president now owns 360 shares in the company, valued at $41,677.20. The disclosure for this sale can be found here. 0.74% of the stock is currently owned by corporate insiders.

A number of institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. increased its stake in Albemarle Corporation by 1.7% in the second quarter. Vanguard Group Inc. now owns 12,501,329 shares of the specialty chemicals company’s stock valued at $1,319,389,000 after purchasing an additional 213,530 shares during the last quarter. BlackRock Inc. increased its stake in Albemarle Corporation by 2,805.3% in the first quarter. BlackRock Inc. now owns 8,310,717 shares of the specialty chemicals company’s stock valued at $877,947,000 after purchasing an additional 8,024,668 shares during the last quarter. Jennison Associates LLC increased its stake in Albemarle Corporation by 12.0% in the second quarter. Jennison Associates LLC now owns 6,421,530 shares of the specialty chemicals company’s stock valued at $677,728,000 after purchasing an additional 689,054 shares during the last quarter. State Street Corp increased its stake in Albemarle Corporation by 0.5% in the first quarter. State Street Corp now owns 6,356,839 shares of the specialty chemicals company’s stock valued at $671,675,000 after purchasing an additional 30,662 shares during the last quarter. Finally, FMR LLC increased its stake in Albemarle Corporation by 3.9% in the first quarter. FMR LLC now owns 2,269,067 shares of the specialty chemicals company’s stock valued at $239,703,000 after purchasing an additional 84,189 shares during the last quarter. Institutional investors own 83.77% of the company’s stock.

About Albemarle Corporation

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Get a free copy of the Zacks research report on Albemarle Corporation (ALB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Albemarle Corporation (NYSE:ALB)

Receive News & Ratings for Albemarle Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Corporation and related companies with MarketBeat.com's FREE daily email newsletter.